Page data last changed: . Chemistry registry snapshot: . Registry refreshes and identity assessments are separate from scientific content review.
Contains a rare D-amino acid at position 2, a hallmark of proteolytically stable frog-skin opioids.
Part of the Neuropeptides & signaling cluster
Overview
Dermorphin is a naturally occurring opioid heptapeptide from the skin of Phyllomedusa frogs and a highly potent, selective mu-opioid receptor agonist. Its D-alanine at position 2 confers unusual stability. It is a research peptide, not a Health Canada-authorized product, and this page is educational only.
Source & context
Biological / chemical source: Skin secretions of South American frogs of the genus Phyllomedusa
Primary research or clinical context: Naturally occurring peptide and research tool; misused historically in animal sport, where it is prohibited — not a Health Canada-authorized product
The D-amino acid signature
Dermorphin, Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2, carries a D-alanine at the second position — an extremely rare feature in vertebrate peptides that resists enzymatic breakdown. This natural D-residue is a classic illustration of how stereochemistry protects a peptide from proteases and is a strategy medicinal chemists deliberately borrow.
Context and misuse
Reported to be many times more potent than morphine at the mu receptor in laboratory assays, dermorphin has been detected as an illicit doping agent in animal racing, where it is banned. This page describes its chemistry and biology for educational purposes only and does not endorse or describe any use in humans or animals.
Structure & chemistry
Molecular identity & reference confidence
Source-supported reference
Reference values are taken from the cited molecular record or curated profile. A database match is not independent laboratory verification; modifications, counter-ions, and formulations can change the measured mass.
- Molecular form
- Dermorphin (source record; form not independently established)
- Species
- Not established by this molecular identity audit
- Termini (N / C)
- Not specified / Not specified
Average reference mass
Reference policy updated: 2026-10-05
- PubChem molecular record · 2026-10-01
- Molecular formula
- C40H50N8O10
- Average reference mass
- ≈ 802.9
- PubChem CID: 5485199
- CAS RN: 77614-16-5
- UNII: 2SEC01B703
Chemistry values: PubChem · fetched 2026-10-01.
Dermorphin — reconstitution calculator
Enter how much peptide is in the vial and how much diluent (e.g. bacteriostatic water) is added. The tool returns the resulting solution concentration — and, for any amount you type, the volume it corresponds to. This is educational arithmetic, not a dosing recommendation.
Reference form: Dermorphin (source record; form not independently established)Average reference mass: 802.9 Da
Enter an amount to see the volume it corresponds to.
Educational concentration mathematics only. This tool does not recommend a dose, amount, or protocol, and nothing here is medical advice. Many peptides are not authorized by Health Canada for human use — see our reconstitution and bacteriostatic-water guides for context.
FAQ about Dermorphin
What is Dermorphin?+
Dermorphin is a naturally occurring opioid heptapeptide from the skin of Phyllomedusa frogs and a highly potent, selective mu-opioid receptor agonist. Its D-alanine at position 2 confers unusual stability. It is a research peptide, not a Health Canada-authorized product, and this page is educational only.
What Canadian product status is recorded for Dermorphin?+
Canadian product status for Dermorphin has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.
What is the typical length of Dermorphin?+
Dermorphin is commonly described as approximately 7 amino acids (Exogenous opioid heptapeptide (frog skin)).
Related peptides
References & further reading
- 1.Mizoguchi et al. (2011). Dermorphin tetrapeptide analogs as potent and long-lasting analgesics with pharmacological profiles distinct from morphine. Peptides
- 2.Melchiorri et al. (1996). The dermorphin peptide family. Gen Pharmacol
- 3.Robinson et al. (2015). Pharmacokinetics and pharmacodynamics of dermorphin in the horse. J Vet Pharmacol Ther
- 4.Zhuang et al. (2026). Dermorphin blocks apneic response to intravenous bolus injection of fentanyl. Toxicol Appl Pharmacol
- 5.Hesselink et al. (2018). Rediscovery of old drugs: the forgotten case of dermorphin for postoperative pain and palliation. J Pain Res
- 6.de Castiglione et al. (1985). Structure-activity relationships of dermorphin synthetic analogues. Peptides
- 7.Ummadisetty et al. (2024). Dermorphin [D-Arg2, Lys4] (1-4) Amide Alleviates Frostbite-Induced Pain by Regulating TRP Channel-Mediated Microglial Activation and Neuroinflammation. Mol Neurobiol
- 8.Amiche et al. (1988). Structural requirements for dermorphin opioid receptor binding. Int J Pept Protein Res
- 9.PubMed — Amino acid composition and sequence of dermorphin (7287299)
- 10.Wikipedia — Dermorphin